Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Camellia PLC on Thursday said it expects approval for the sale of its holding in BF&M Ltd to Bermuda Life Insurance Co Ltd to be delayed into the first quarter of the current year.
The Kent-based agriculture and engineering services firm in June said it will sell its entire 37% stake in BF&M to Bermuda Life Insurance Co Ltd, a subsidiary of Argus Group Holdings Ltd, for $100.0 million. It is conditional upon regulatory and tax approvals.
Camellia explained that after its proposed disposal, BF&M’s board implemented a shareholder rights agreement which has since been removed.
Further, BF&M has separately announced a partnership with Equilibria Capital Management Ltd, which is Argus’s major shareholder. Under the partnership, BF&M has committed to a ‘significant’ investment in a dedicated Equilibria Investment fund which will include an initial investment in respect of a 16.3% stake in Argus.
Camellia said that these developments have impacted the expected timetable for regulatory approval for its disposals of its 37% stake in BF&M to Bermuda Life Insurance.
The company added that a gain on disposal of about £1.9 million will be reflected in its 2023 results.
Camellia shares rose 2.7% to 5,095.00 pence each on Thursday in London.
Copyright 2024 Alliance News Ltd. All Rights Reserved.